Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$27.24 USD
+25.72 (1,692.11%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $27.24 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VOR 27.24 +25.72(1,692.11%)
Will VOR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VOR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VOR
Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
VOR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VOR
Is VOR poised for a decline? New Downtrend shows up after crashing 10.23%
NR7 appears for VOR after 0.0% move
First Look: Nvidia's Strategic Moves and FedEx's Earnings Outlook
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale
Vor Biopharma trading halted on Thursday, news pending